{"id":304550,"date":"2026-10-13T10:50:56","date_gmt":"2026-10-13T05:20:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=304550"},"modified":"2026-10-13T10:50:56","modified_gmt":"2026-10-13T05:20:56","slug":"vaccine-global-generic-and-ophthalmology-stocks-forward-view-shortlist","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/vaccine-global-generic-and-ophthalmology-stocks-forward-view-shortlist\/","title":{"rendered":"3 Vaccine, Global Generic and Ophthalmology Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Aurobindo Pharma and Dr. Agarwal’s Health Care"},"content":{"rendered":"

GSK Pharma Rs 2,531.50, P\/E 40.20. Aurobindo Pharma Rs 1,706.90, P\/E 25.46. Dr. Agarwal’s Health Care Rs 475.20, P\/E 80.51. Closing prices of 12 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Vaccine, global generic and ophthalmology stocks with the clearest long-term roadmaps today include GSK Pharma in branded medicines and vaccines, Aurobindo Pharma in generic formulations and active ingredients for global markets and Dr. Agarwal’s Health Care in eye care hospitals and clinics. FY26 revenue growth was 1.8% at GSK Pharma, 5.6% at Aurobindo Pharma and 20.9% at Dr. Agarwal’s Health Care. P\/E stands at 40.20 for GSK Pharma (industry 37.59), 25.46 for Aurobindo Pharma (industry 37.59) and 80.51 for Dr. Agarwal’s Health Care (industry 62.79). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Vaccine, global generic and ophthalmology stocks give investors exposure to vaccines, generic medicines and eye care that patients depend on. Prescription growth, export approvals and hospital additions decide how much of that demand turns into profit.<\/p>\n

This list covers three vaccine, global generic and ophthalmology stocks: GlaxoSmithKline Pharmaceuticals for branded medicines and vaccines, Aurobindo Pharma for generic formulations and active ingredients for global markets and Dr. Agarwal’s Health Care for eye care hospitals and clinics. Every figure comes from the latest reported financials and the 12 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n